Bernie Rudnick

About

After several successful C-level positions with biotechnology companies including Immunomic Therapeutics and Atrin Pharmaceuticals, Mr. Rudnick, along with Dr. Andy Luber, Dr. Hildegund Ertl and the Wistar Institute, co-founded Virion Therapeutics. Virion, the developer of the first checkpoint inhibitor powered vaccines, holds the promise of ameliorating virally induced cancers and chronic infectious disease. Rudnick is founder and managing partner of CapGenic Advisors, LLC, and a member of several angel groups. He is a founder of one of the nation’s leading entrepreneurial programs (MADV) at the Fox School of Business. He is a director of SageMedic, formerly CFO and currently director of Atrin Pharmaceuticals, former director and CFO of Immunomic Therapeutics, and holds or has held a number of additional board seats both commercial and not-for-profit – throughout his career. Mr. Rudnick has executive management, senior merger, acquisition, capital formation and licensing leadership e

Investment Focus

Location

Newark, US